David Aronson
CEO
Standard Seed Corporation
This startup provides AI-powered reports for botanical research, helping pharmaceutical companies discover new drug leads from natural resources. Their platform analyzes complex natural chemistry to identify potential medicinal compounds.
- Artificial Intelligence
- Biotechnology
Updated 6 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Problem
The process of identifying and developing new drugs from botanical sources is often slow, inefficient, and hampered by fragmented, disorganized chemical data, making it difficult to draw meaningful conclusions about therapeutic potential. Navigating the complex regulatory landscape for botanical drugs, nutraceuticals, and dietary supplements further compounds these challenges.
Solution
Standard Seed Corporation has developed an AI-driven platform that digitizes and analyzes detailed plant-based chemical information to accelerate drug discovery and development. The platform maps plant chemicals to the human body, providing insights into their medico-therapeutic capacity and enabling the identification of potential natural therapies. By integrating literature analysis, chemical analysis, clinical studies, and regulatory compliance, the AI system streamlines the process of preparing Investigational New Drug (IND) and New Dietary Ingredient (NDI) applications, bridging the gap between botanical research and FDA approval.
Target Audience
The primary target audience includes formulation developers, chemical manufacturers, and pharmaceutical companies seeking to develop new drugs, nutraceuticals, and dietary supplements from botanical sources.
Features
- Multi-agent AI system for literature analysis, chemical analysis, clinical studies, dosage optimization, retrosynthesis, regulatory compliance, risk assessment, and molecular dynamics
- Compound characterization using advanced AI algorithms to analyze molecular structures and properties
- Chemical disease pathway analysis detailing how compounds interact with biological targets
- Computational biology tools including molecular docking and molecular dynamics simulations
- AI-powered prediction of compound solubility, solvate prediction, and polymorphic prediction
- Green retrosynthesis for AI-generated environmentally friendly synthetic routes
- Excipient testing for analysis of compound compatibility with various excipients
- Toxicology assessments providing comprehensive safety and toxicity predictions
- AI-generated citations and sources using RAG (Retrieval-Augmented Generation) technology